STRAUMANN HOLDING AG

Straumann Holding AG posts 2025 growth: CHF 2.6 b revenue, CHF 3.0 EPS, and a strong 15.4 % margin, driven by digital‑dentistry innovation, global expansion and robust cash flow, positioning for 2026 success.

Discover how Straumann Holding AG’s February earnings reveal the future of global dental‑implant markets, spotlighting supply‑chain risks, regulatory shifts, and digital‑dental opportunities for investors.

Explore how Straumann’s proven dental implants and bone grafts keep it strong amid flat Swiss markets—high survival rates, low peri‑implantitis, and solid regulatory backing.

Explore Straumann Holding’s 2025 results webcast, uncovering the dental‑implant company’s financial health, regulatory risks, and growth opportunities in a tech‑driven market.

Discover how Straumann Holding AG’s solid margins, strategic US/Swiss pricing, and new titanium‑free implant launch shape its market outlook and patient access strategy.

Swiss shares snapshot: Straumann Holding dips while the SMI hits a near‑record high – a market‑driven move, no company news, and steady dental‑implant prospects.

Straumann Holding AG: Stable shares, premium valuation, and growth driven by premium implant tech, AI‑enabled planning, and sustainability‑focused sourcing.

Straumann’s investor day reveals a 10% revenue‑growth plan, margin boost, and digital‑dental innovations, positioning the Swiss implant maker for long‑term upside.

Explore Straumann Holding AG’s Q1 2024 surge: record revenue, cost‑saving wins, ESG goals and value‑based pricing boosting investor confidence.

Straumann Holding AG, a leading Swiss dental implant provider, is poised for long-term growth due to its diversified product portfolio, technological advancements, and strong financial position, despite recent short-term market volatility.